首页> 外文学位 >Effects of taurine and chemically-related sulfur-containing compounds on oxidant- and nonoxidant-induced red blood cell membrane damage and antioxidant status.
【24h】

Effects of taurine and chemically-related sulfur-containing compounds on oxidant- and nonoxidant-induced red blood cell membrane damage and antioxidant status.

机译:牛磺酸和化学相关的含硫化合物对氧化剂和非氧化剂诱导的红细胞膜损伤和抗氧化状态的影响。

获取原文
获取原文并翻译 | 示例

摘要

This study has evaluated the actions of taurine (TAU), twelve sulfur-containing structurally related to TAU (N-(2-acetamido)-2-aminoethanesufonic acid, aminomethane-suffonic acid, N-acetylcysteine, L-cysteic acid, α-sufo-β-alanine, ethane-sulfonic acid, 1,2-ethanedisulfonic acid, homotaurine, hypotaurine, isethionic acid, 3mercaptoeth-anesufonic acid, N-methyltaurine) and cromolyn sodium (CROM) on oxidant and nonoxidant-induced cell damage. Using hydrogen peroxide (H 2O2), phenylhydrazine (PHZ) and tert-butyl hydroperoxide (bhp) as model oxidants, and intact rat erythrocytes (RBCs) as a test system, indices of membrane damage (i.e., hemoglobin, lactate dehydrogenase, potassium ions) and of antioxidative status (i.e., reduced glutathione, methemoglobin, catalase, glutathione peroxidase, superoxide dismutase) were measured. TAU (25–175 mM) protected RBCs against oxidant-induced cell damage and impairment of the antioxidative defenses in a manner and to an extent that were dependent on both its concentration and that of the oxidant (H2O2: 5–40 mM; PHZ: 75–100, tBHP: 0.5–3 mM). By treating rats with TAU (2.4 mM/kg, divided doses, ip) before a single dose of PHZ (75 mg/kg, ip), it was verified that TAU was also able to protect RBCs under in vivo conditions. Through the use of cholic acid (CHOLAC), saponin (SAP) and hypoosmotic (0.4%) NaCl as nonoxidant hemolyzing agents, it was shown that TAU protected RBCs only against CHOLAC- and 0.4% NaCl-related cellular damage. From the results of in vitro and in vivo experiments with compounds representing analogs and homologs of TAU, it was determined that the protective actions of this amino acid against oxidant- and nonoxidant-induced RBC alterations are centered on its sufonate group. Structural alterations of the TAU molecule such as chain length, N-substitution, α- or β-carboxylation, reduction of the sufonate to a sulfinate group, deamination and replacement of the amino group by another functionality exerted variable effects on the protection by TAU. N-Methylation and replacement of a sulfhydryl group for the β-amino group, on the other hand, abolished the protective properties of TAU. Moreover, protection by TAU and its congeners appeared to take place extracellularly and through weak, noncovalent interactions, since the protection disappeared upon washing RBCs that had been pretreated with a sulfur-containing compound with buffer solution, and since it remained unaltered in the presence of β-alanine, an inhibitor of TAU uptake into cells. In contrast, protection by CROM, a known membrane stabilizer, was unaffected by the washing step.
机译:这项研究评估了牛磺酸(TAU)的作用,牛磺酸(TAU)在结构上与TAU有关(N-(2-乙酰氨基)-2-氨基乙烷磺酸,氨基甲烷-磺酸,N-乙酰半胱氨酸,L-半胱氨酸,α- Sufo-β-丙氨酸,乙烷磺酸,1,2-乙烷二磺酸,高牛磺酸,次牛磺酸,异乙酸,3-巯基-异磺酸,N-甲基牛磺酸)和色甘酚钠(CROM)对氧化剂和非氧化剂引起的细胞损伤。使用过氧化氢(H 2 O 2 ),苯肼(PHZ)和叔丁基过氧化氢(bhp)作为模型氧化剂,并使用完整的大鼠红细胞(RBC)作为测试在该系统中,测量了膜损伤(即血红蛋白,乳酸脱氢酶,钾离子)和抗氧化状态(即还原型谷胱甘肽,高铁血红蛋白,过氧化氢酶,谷胱甘肽过氧化物酶,超氧化物歧化酶)的指标。 TAU(25–175 mM)以某种方式和程度取决于其浓度和氧化剂(H 2 )来保护红细胞免受氧化剂诱导的细胞损伤和抗氧化防御能力的损害。 O 2 :5-40 mM; PHZ:75-100,tBHP:0.5-3 mM)。通过在单剂量PHZ(75 mg / kg,ip)之前用TAU(2.4 mM / kg,分次剂量,ip)治疗大鼠,已证实TAU也能够在体内条件下保护RBC。通过使用胆酸(CHOLAC),皂苷(SAP)和低渗(0.4%)NaCl作为非氧化剂溶血剂,表明TAU仅能保护RBC免受CHOLAC和0.4%NaCl相关的细胞损伤。从用代表TAU的类似物和同系物的化合物进行的体外和体内实验的结果中,可以确定该氨基酸对氧化剂和非氧化剂诱导的RBC改变的保护作用集中在其磺酰脲基上。 TAU分子的结构改变,例如链长,N-取代,α-或β-羧基化,将磺酰氨基磺酸盐还原成亚磺酸盐基团,氨基被另一个官能团脱氨基和取代,对TAU的保护产生了可变的影响。另一方面,N-甲基化和巯基取代β-氨基消除了TAU的保护性能。此外,TAU及其同类物的保护作用似乎发生在细胞外,并且通过弱的非共价相互作用发生,因为在用缓冲溶液洗涤含硫化合物预处理的RBC时,保护作用消失了,并且在存在H2O的情况下保持不变。 β-丙氨酸,TAU摄取进入细胞的抑制剂。相反,通过CROM(一种已知的膜稳定剂)的保护不受洗涤步骤的影响。

著录项

  • 作者

    Pokhrel, Prabhat Kumar.;

  • 作者单位

    St. John's University (New York), School of Pharmacy.;

  • 授予单位 St. John's University (New York), School of Pharmacy.;
  • 学科 Health Sciences Pharmacology.; Health Sciences Toxicology.
  • 学位 Ph.D.
  • 年度 2001
  • 页码 252 p.
  • 总页数 252
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;毒物学(毒理学);
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号